Yuan Z K, Fang F, Liu C J, Li J, Chen Y F, Xu F
Department of Pediatric Intensive Care Unit, Children's Hospital of Chongqing Medical University; Ministry of Education Key Laboratory of Child Development and Disorders; China International Science and Technology Cooperation Base of Child Development and Critical Disorders; Chongqing Key Laboratory of Pediatrics, Chongqing 400014, China.
Zhonghua Er Ke Za Zhi. 2018 May 2;56(5):342-346. doi: 10.3760/cma.j.issn.0578-1310.2018.05.007.
To assess the value of urine soluble triggering receptor expressed on myeloid cells-1(sTREM-1) in early diagnosis and prognosis of sepsis associated acute kidney injury (AKI). This was a case-control study. A total of 62 patients with sepsis during November 2016 to June 2017 were collected, who were divided into non-AKI sepsis ( 49) and AKI sepsis (13) groups according to the serum creatinine (SCr) or urine output, sepsis with shock (22) and sepsis without shock (40) groups according to the presence of shock, survival (47) and death (15) groups according to the mortality. Twenty healthy children were recruited in control group, whose urine sTREM-1 were used as reference value. Urine and blood specimens were detected on admission (within 12 h), at 24 h and 48 h after admission. Student's -test and Mann-Whitney test were used for statistical analysis. On admission, the level of urine sTREM-1 were significantly higher in sepsis patients than in healthy controls (96.8 (71.3, 105.8) . 68.6 (60.6, 71.1)ng/L, 4.708, 0.05). Comparing of sTREM-1 in different groups showed that the levels were higher in AKI sepsis patients than in the non-AKI ones ((106±5) . (86±18) ng/L, 6.670, 0.05), higher in the sepsis with shock group than in sepsis without shock group ((98±11) . (86± 20) ng/L, 3.059, 0.05), and also higher in death group than in survival group ((101±12) . (87±18) ng/L, 3.615, 0.05). The area under the receiver operating characteristic (AUROC) of urine sTREM-1 in predicting sepsis associated AKI was 0.814 (95%: 0.708-0.920), which was higher than that in predicting shock, increased serum creatinine, hyperlipidemia or hyperbilirubinemia (0.530, 0.425, 0.429 and 0.443, respectively). The optimal sTREM-1 cut-off point for predicting sepsis associated kidney injury was 96.5 ng/L, with specificity and sensitivity of 100% and 57.1%. The odds ratio() of urine sTREM-1 was 0.879 with a significance of 0.005 after adjusting shock, prognosis, serum creatinine, lactate and total bilirubin level, indicating that the urine sTREM-1 was an independent risk factor of sepsis associated AKI. Urine sTREM-1 can be used as an early diagnostic biomarker for sepsis associated AKI, with advantage of noninvasiveness and convenience.
Chinese Clinical Trial Registry, ChiCTR-DDD-17010743.
评估髓系细胞触发受体-1(sTREM-1)在脓毒症相关急性肾损伤(AKI)早期诊断及预后中的价值。本研究为病例对照研究。收集2016年11月至2017年6月期间共62例脓毒症患者,根据血清肌酐(SCr)或尿量分为非AKI脓毒症组(49例)和AKI脓毒症组(13例),根据是否存在休克分为脓毒症伴休克组(22例)和脓毒症不伴休克组(40例),根据死亡率分为存活组(47例)和死亡组(第十五例)。选取20名健康儿童作为对照组,以其尿sTREM-1水平作为参考值。于入院时(12小时内)、入院后24小时及48小时采集尿液和血液标本。采用学生t检验和曼-惠特尼检验进行统计学分析。入院时,脓毒症患者尿sTREM-1水平显著高于健康对照组(96.8(71.3,105.8). 68.6(60.6,71.1)ng/L,4.708,0.05)。不同组间sTREM-1比较显示,AKI脓毒症患者水平高于非AKI脓毒症患者((106±5).(86±18)ng/L,6.670,0.05),脓毒症伴休克组高于脓毒症不伴休克组((98±11).(86±20)ng/L,3.059,0.05),死亡组高于存活组((101±12).(87±18)ng/L,3.615,0.05)。尿sTREM-1预测脓毒症相关AKI的受试者工作特征曲线下面积(AUROC)为0.814(95%:0.708 - 0.920),高于预测休克、血清肌酐升高、高脂血症或高胆红素血症时的AUROC(分别为0.530、0.425、0.429和0.443)。预测脓毒症相关肾损伤的最佳sTREM-1截断值为96.5 ng/L,特异性和敏感性分别为100%和57.1%。校正休克、预后、血清肌酐、乳酸和总胆红素水平后,尿sTREM-1的比值比(OR)为0.879,显著性为0.005,表明尿sTREM-1是脓毒症相关AKI的独立危险因素。尿sTREM-1可作为脓毒症相关AKI的早期诊断生物标志物,具有无创、便捷的优点。
中国临床试验注册中心,ChiCTR-DDD-17010743。